These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14579716)

  • 1. [Development of therapies of Alzheimer's disease].
    Shoji M
    Nihon Ronen Igakkai Zasshi; 2003 Sep; 40(5):473-5. PubMed ID: 14579716
    [No Abstract]   [Full Text] [Related]  

  • 2. Is an effective immune intervention for Alzheimer's disease in prospect?
    Esiri MM
    Trends Pharmacol Sci; 2001 Jan; 22(1):2-3. PubMed ID: 11165659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refining an Alzheimer's vaccine to avoid an inflammatory response.
    Brown ME; DaSilva KA; McLaurin J
    Expert Opin Biol Ther; 2005 Jun; 5(6):809-16. PubMed ID: 15952911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of beta-amyloid peptide in pathogenesis and immunotherapy of Alzheimer's diseases].
    Yu SN; Liu LY; Liang P
    Zhonghua Bing Li Xue Za Zhi; 2005 Feb; 34(2):113-4. PubMed ID: 15842811
    [No Abstract]   [Full Text] [Related]  

  • 5. Aβ immunotherapy for Alzheimer's disease: where are we?
    Güell-Bosch J; Montoliu-Gaya L; Esquerda-Canals G; Villegas S
    Neurodegener Dis Manag; 2016 Jun; 6(3):179-81. PubMed ID: 27230296
    [No Abstract]   [Full Text] [Related]  

  • 6. Update on Elan vaccine for Alzheimer's disease.
    Spinney L
    Lancet Neurol; 2004 Jan; 3(1):5. PubMed ID: 14703630
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current status of Alzheimer's disease immunotherapy and pharmacologic effect of BAN2401.].
    Araki S
    Nihon Yakurigaku Zasshi; 2010 Jul; 136(1):21-5. PubMed ID: 20628209
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of Alzheimer's disease: the beginning of a new era.
    Schenk D
    Curr Alzheimer Res; 2006 Jul; 3(3):177. PubMed ID: 16842091
    [No Abstract]   [Full Text] [Related]  

  • 9. Amyloid beta peptide immunotherapy in Alzheimer disease.
    Delrieu J; Ousset PJ; Voisin T; Vellas B
    Rev Neurol (Paris); 2014 Dec; 170(12):739-48. PubMed ID: 25459121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease.
    Hock C; Konietzko U; Streffer JR; Tracy J; Signorell A; Müller-Tillmanns B; Lemke U; Henke K; Moritz E; Garcia E; Wollmer MA; Umbricht D; de Quervain DJ; Hofmann M; Maddalena A; Papassotiropoulos A; Nitsch RM
    Neuron; 2003 May; 38(4):547-54. PubMed ID: 12765607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's amyloid immunotherapy: quo vadis?
    Gandy S; Heppner FL
    Lancet Neurol; 2005 Aug; 4(8):452-3. PubMed ID: 16033686
    [No Abstract]   [Full Text] [Related]  

  • 12. Active Immunotherapy to Prevent Alzheimer Disease-A DNA Amyloid β 1-42 Trimer Vaccine.
    Rosenberg RN; Lambracht-Washington D
    JAMA Neurol; 2020 Mar; 77(3):289-290. PubMed ID: 31816028
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel antibody targeting sequence 31-35 in amyloid β protein attenuates Alzheimer's disease-related neuronal damage.
    Cheng L; Zhang J; Li XY; Yuan L; Pan YF; Chen XR; Gao TM; Qiao JT; Qi JS
    Hippocampus; 2017 Feb; 27(2):122-133. PubMed ID: 27784133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease.
    Matsuo K; Okamoto H; Kawai Y; Quan YS; Kamiyama F; Hirobe S; Okada N; Nakagawa S
    J Neuroimmunol; 2014 Jan; 266(1-2):1-11. PubMed ID: 24315156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse models reveal why Alzheimer's treatment fails.
    Niemeyer JE
    Lab Anim (NY); 2016 Apr; 45(4):125. PubMed ID: 27003340
    [No Abstract]   [Full Text] [Related]  

  • 16. Prophylactic Vaccine Based on Pyroglutamate-3 Amyloid β Generates Strong Antibody Response and Rescues Cognitive Decline in Alzheimer's Disease Model Mice.
    Li G; Hu ZW; Chen PG; Sun ZY; Chen YX; Zhao YF; Li YM
    ACS Chem Neurosci; 2017 Mar; 8(3):454-459. PubMed ID: 28292186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased amyloid-β and increased neuronal hyperactivity by immunotherapy in Alzheimer's models.
    Busche MA; Grienberger C; Keskin AD; Song B; Neumann U; Staufenbiel M; Förstl H; Konnerth A
    Nat Neurosci; 2015 Dec; 18(12):1725-7. PubMed ID: 26551546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of prevention and treatment of Alzheimer's disease: a minireview].
    Tabira T
    Nihon Ronen Igakkai Zasshi; 2004 Jan; 41(1):23-5. PubMed ID: 14999905
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoantibodies to beta-amyloid and neurotransmitters in patients with Alzheimer's disease and senile dementia of the Alzheimer type.
    Myagkova MA; Gavrilova SI; Lermontova NN; Kalyn YB; Selezneva ND; Zharikov GA; Kolykhalov IV; Abramenko TV; Serkova TP; Bachurin SO
    Bull Exp Biol Med; 2001 Feb; 131(2):127-9. PubMed ID: 11391392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amyloid-beta protein vaccine therapy for alzheimer's disease].
    Hara H
    Nihon Naika Gakkai Zasshi; 2006 Jun; 95(6):1122-8. PubMed ID: 16846064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.